Pamela Vig - Sep 29, 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Signature
/s/ Jody Howe, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Sep 29, 2021
Transactions value $
-$26,265
Form type
4
Date filed
10/1/2021, 08:00 PM
Previous filing
May 12, 2021
Next filing
Nov 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $0 +8.13K +279.59% $0.00 11K Sep 29, 2021 Direct F1
transaction MIRM Common Stock Sale -$26.3K -1.36K -12.37% $19.26 9.67K Oct 1, 2021 Direct F2
holding MIRM Common Stock 75K Sep 29, 2021 By The Vig-Ancock Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares became issuable upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of a performance-based restricted stock unit award on March 9, 2021. On September 29, 2021, the Compensation Committee certified the achievement of the performance criteria resulting in the vesting of 4,062 shares on September 29, 2021 and 4,063 shares on June 30, 2023.
F2 Shares sold to cover tax withholding obligations associated with the vesting of the performance-based restricted stock unit award granted to the Reporting Person on March 9, 2021.